A deep learning pipeline for morphological and viability assessment of 3D cancer cell spheroids

Research output: Contribution to journalArticlepeer-review

Abstract

Three-dimensional (3D) spheroid models have advanced cancer research by better mimicking the tumour microenvironment compared to traditional two-dimensional cell cultures. However, challenges persist in high-throughput analysis of morphological characteristics and cell viability, as traditional methods like manual fluorescence analysis are labour-intensive and inconsistent. Existing AI-based approaches often address segmentation or classification in isolation, lacking an integrated workflow. We propose a scalable, two-stage deep learning pipeline to address these gaps: (i) a U-Net model for precise detection and segmentation of 3D spheroids from microscopic images, achieving 95% prediction accuracy, and (ii) a CNN Regression Hybrid method for estimating live/dead cell percentages and classifying spheroids, with an R2value of 98%. This end-to-end pipeline automates cell viability quantification and generates key morphological parameters for spheroid growth kinetics. By integrating segmentation and analysis, our method addresses environmental variability and morphological characterization challenges, offering a robust tool for drug discovery, toxicity screening, and clinical research. This approach significantly improves efficiency and scalability of 3D spheroid evaluations, paving the way for advancements in cancer therapeutics.

Original languageEnglish
Article numberbpaf030
JournalBiology Methods and Protocols
Volume10
Issue number1
DOIs
Publication statusPublished - 2025

Keywords

  • artificial intelligence
  • convolutional neural network
  • drug discovery
  • high-throughput screening
  • live/dead assay
  • spheroid viability
  • toxicology
  • U-Net

Fingerprint

Dive into the research topics of 'A deep learning pipeline for morphological and viability assessment of 3D cancer cell spheroids'. Together they form a unique fingerprint.

Cite this